These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 35185922)

  • 1. The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease.
    Thomas JP; Modos D; Rushbrook SM; Powell N; Korcsmaros T
    Front Immunol; 2022; 13():829525. PubMed ID: 35185922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis.
    Di Vincenzo F; Puca P; Lopetuso LR; Petito V; Masi L; Bartocci B; Murgiano M; De Felice M; Petronio L; Gasbarrini A; Scaldaferri F
    Nutrients; 2022 Jun; 14(13):. PubMed ID: 35807844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile Acid-Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside.
    Yang M; Gu Y; Li L; Liu T; Song X; Sun Y; Cao X; Wang B; Jiang K; Cao H
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
    Gasaly N; de Vos P; Hermoso MA
    Front Immunol; 2021; 12():658354. PubMed ID: 34122415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiome in primary sclerosing cholangitis: A review.
    Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
    World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease.
    Li L; Liu T; Gu Y; Wang X; Xie R; Sun Y; Wang B; Cao H
    Front Immunol; 2022; 13():974305. PubMed ID: 36211363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile Acid Signaling in Inflammatory Bowel Disease.
    Bromke MA; Krzystek-Korpacka M
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review: bile acids and intestinal inflammation-luminal aggressors or regulators of mucosal defence?
    Pavlidis P; Powell N; Vincent RP; Ehrlich D; Bjarnason I; Hayee B
    Aliment Pharmacol Ther; 2015 Oct; 42(7):802-17. PubMed ID: 26223936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bad "Good" Bile Acids and Gut Microbiota Dysbiosis in Inflammatory Bowel Disease: Mice and Humans Are Not the Same.
    Sitkin S; Pokrotnieks J
    Dig Dis Sci; 2021 Mar; 66(3):925-927. PubMed ID: 33063190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis.
    Pan Y; Zhang H; Li M; He T; Guo S; Zhu L; Tan J; Wang B
    Gut Microbes; 2024; 16(1):2356284. PubMed ID: 38769683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease.
    Weng YJ; Gan HY; Li X; Huang Y; Li ZC; Deng HM; Chen SZ; Zhou Y; Wang LS; Han YP; Tan YF; Song YJ; Du ZM; Liu YY; Wang Y; Qin N; Bai Y; Yang RF; Bi YJ; Zhi FC
    J Dig Dis; 2019 Sep; 20(9):447-459. PubMed ID: 31240835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease.
    Hu Y; Chen Z; Xu C; Kan S; Chen D
    Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metagenomic analysis of bile salt biotransformation in the human gut microbiome.
    Das P; Marcišauskas S; Ji B; Nielsen J
    BMC Genomics; 2019 Jun; 20(1):517. PubMed ID: 31234773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease.
    Lavelle A; Sokol H
    Nat Rev Gastroenterol Hepatol; 2020 Apr; 17(4):223-237. PubMed ID: 32076145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in Bile Acid Metabolism Associated With Inflammatory Bowel Disease.
    Li N; Zhan S; Tian Z; Liu C; Xie Z; Zhang S; Chen M; Zeng Z; Zhuang X
    Inflamm Bowel Dis; 2021 Aug; 27(9):1525-1540. PubMed ID: 33399195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet-Microbiota Interactions in Inflammatory Bowel Disease.
    Sugihara K; Kamada N
    Nutrients; 2021 May; 13(5):. PubMed ID: 34062869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets.
    Santana PT; Rosas SLB; Ribeiro BE; Marinho Y; de Souza HSP
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation.
    Xu M; Cen M; Shen Y; Zhu Y; Cheng F; Tang L; Hu W; Dai N
    Dig Dis Sci; 2021 Feb; 66(2):568-576. PubMed ID: 32198567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases.
    Parada Venegas D; De la Fuente MK; Landskron G; González MJ; Quera R; Dijkstra G; Harmsen HJM; Faber KN; Hermoso MA
    Front Immunol; 2019; 10():277. PubMed ID: 30915065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.